These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14592907)

  • 1. Role of Munc18-1 in synaptic plasticity at the myasthenic neuromuscular junction.
    Sons MS; Verhage M; Plomp JJ
    Ann N Y Acad Sci; 2003 Sep; 998():404-6. PubMed ID: 14592907
    [No Abstract]   [Full Text] [Related]  

  • 2. Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.
    Wang X; Rich MM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):170-177. PubMed ID: 28981978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM; Drachman DB; Satyamurti S
    Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome.
    Gomez CM; Maselli R; Williams JM; Bhattacharyya BB; Wollmann RL; Day JW
    Ann N Y Acad Sci; 1998 May; 841():167-80. PubMed ID: 9668235
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 6. Repetitive nerve stimulation in studies of respiratory involvement in myasthenia gravis.
    Zifko U; Bolton CB; Nicolle MW
    Ann N Y Acad Sci; 1998 May; 841():716-9. PubMed ID: 9668319
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis as a receptor disorder.
    Drachman DB; Kao I; Pestronk A; Toyka KV
    Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuromuscular defect after suppression of ion conductance.
    Takamori M; Ide Y; Kasai M
    Neurology; 1979 Jun; 29(6):772-9. PubMed ID: 221854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of decremental response in decentralized muscles of a myasthenic patient.
    Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
    Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia gravis and other neuromuscular diseases].
    Pirskanen R
    Duodecim; 1979; 95(21):1401-11. PubMed ID: 527509
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of myasthenic IgG on miniature end-plate currents in mouse diaphragm.
    Pennefather P; Quastel DM
    Life Sci; 1980 Dec; 27(22):2047-54. PubMed ID: 7207007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavioral of evoked potentials in repeated stimulation of the facial nerve and electromyographic diagnosis of myasthenia gravis].
    Bassi S; Crespi V; Passerini D; Smirne S
    Riv Neurol; 1975; 45(1):60-3. PubMed ID: 167419
    [No Abstract]   [Full Text] [Related]  

  • 15. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis.
    Kim YI; Sanders DB
    Exp Neurol; 1981 Jul; 73(1):1-19. PubMed ID: 6265267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disorders of neuromuscular transmission].
    Kwieciński H
    Neurol Neurochir Pol; 1998; 32 Suppl 1():13-21. PubMed ID: 9608549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

  • 19. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 20. Incrementing responses in myasthenia gravis.
    Mayer RF; Williams IR
    Arch Neurol; 1974 Jul; 31(1):24-6. PubMed ID: 4365402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.